Cargando…
G protein–biased GPR3 signaling ameliorates amyloid pathology in a preclinical Alzheimer’s disease mouse model
Biased G protein–coupled receptor (GPCR) ligands, which preferentially activate G protein or β-arrestin signaling pathways, are leading to the development of drugs with superior efficacy and reduced side effects in heart disease, pain management, and neuropsychiatric disorders. Although GPCRs are im...
Autores principales: | Huang, Yunhong, Rafael Guimarães, Thais, Todd, Nicholas, Ferguson, Carolyn, Weiss, Kathryn M., Stauffer, Fiona R., McDermott, Breanne, Hurtle, Bryan T., Saito, Takashi, Saido, Takaomi C., MacDonald, Matthew L., Homanics, Gregg E., Thathiah, Amantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546571/ https://www.ncbi.nlm.nih.gov/pubmed/36161942 http://dx.doi.org/10.1073/pnas.2204828119 |
Ejemplares similares
-
GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation
por: Todd, Nicholas K., et al.
Publicado: (2022) -
Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling
por: Pimenova, Anna A., et al.
Publicado: (2014) -
β-Arrestin2 arrests the clearance of tau in FTLD
por: Thathiah, Amantha
Publicado: (2020) -
Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
por: SAIDO, Takaomi C.
Publicado: (2013) -
MUC1: A multifunctional cell surface component of reproductive tissue epithelia
por: Brayman, Melissa, et al.
Publicado: (2004)